Filter Results :

Your search for Cancer Drug Market returned 120 reports

Sort by


United States Cancer Treatment Drugs Market by Manufacturers, States, Type and Application, Forecast to 2022

18 Jul 2017  |  Published by:  Global Info Research
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.Scope of the Report:This report focuses on the Cancer Treatment Drugs in ...

$ 4,480.00

Read More

Global Gynecological Cancers Drug Market Research Report 2017

03 Jul 2017  |  Published by:  QYResearch
In this report, the global Gynecological Cancers Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.Geographically, this report is segmented into several key Regions, with production, consumption,...

$ 2,900.00

Read More

Global Prostate Cancer Drugs Market Research Report Forecast 2017 to 2021

26 Jun 2017  |  Published by:  S&P Consulting
The Global Prostate Cancer Drugs Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Prostate Cancer Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable)....

$ 2,800.00

Read More

Global Specific Cancer Immunotherapy Drugs Market Research Report 2017

22 Jun 2017  |  Published by:  9Dimen Research
Specific Cancer Immunotherapy Drugs Report by Material, Application, and Geography - Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (U...

$ 2,850.00

Read More

Global Specific Cancer Immunotherapy Drugs Market Research Report Forecast 2017 to 2021

07 Jun 2017  |  Published by:  S&P Consulting
The Global Specific Cancer Immunotherapy Drugs Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Specific Cancer Immunotherapy Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and ...

$ 2,800.00

Read More

Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jun 2017  |  Published by:  DelveInsight
Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Breast Cancer Report is to understand the market a...

$ 2,000.00

Read More

Cancer Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jun 2017  |  Published by:  DelveInsight
Cancer Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Cancer Pain Report is to understand the market and p...

$ 2,000.00

Read More

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jun 2017  |  Published by:  DelveInsight
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key o...

$ 2,000.00

Read More

Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jun 2017  |  Published by:  DelveInsight
Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Lung Cancer Report is to understand the market and p...

$ 2,000.00

Read More

Metastatic Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jun 2017  |  Published by:  DelveInsight
Metastatic Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Metastatic Prostate Cancer Report is ...

$ 2,000.00

Read More

Non-Small Cell Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jun 2017  |  Published by:  DelveInsight
Non-Small Cell Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Non-Small Cell Lung Cancer Report is ...

$ 2,000.00

Read More

Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jun 2017  |  Published by:  DelveInsight
Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Ovarian Cancer Report is to understand the market...

$ 2,000.00

Read More

Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jun 2017  |  Published by:  DelveInsight
Prostate Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Prostate Cancer Report is to understand the mark...

$ 2,000.00

Read More

Rectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jun 2017  |  Published by:  DelveInsight
Rectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Rectal Cancer Report is to understand the market a...

$ 2,000.00

Read More

Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jun 2017  |  Published by:  DelveInsight
Bladder Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Bladder Cancer Report is to understand the market...

$ 2,000.00

Read More
Total 120 records.